Aeterna Zentaris and Ceapro announced that the Court of King’s Bench of Alberta has issued a final order approving the arrangement described in the previously announced definitive agreement to combine the operations of Ceapro and Aeterna in an all-stock merger of equals transaction. The parties anticipate completing the Transaction in the second quarter of 2024, subject to obtaining all required approvals and satisfying all required conditions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AEZS:
- Aeterna Zentaris Financials Affirm Compliance
- Aeterna Zentaris Completes Key Trial Enrollment
- Aeterna Zentaris Completes Trial Enrollment, Plans Merger
- Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency
- Is AEZS a Buy, Before Earnings?